BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1020 related articles for article (PubMed ID: 29768063)

  • 1. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulated circular RNA hsa_circ_0067934 contributes to glioblastoma progression through activating PI3K-AKT pathway.
    Xin J; Zhang XY; Sun DK; Tian LQ; Xu P
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3447-3454. PubMed ID: 31081099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SAMMSON Knockdown Inhibits the Malignancy of Glioblastoma Cells by Inactivation of the PI3K/Akt Pathway.
    Ni H; Wang K; Xie P; Zuo J; Liu W; Liu C
    Cell Mol Neurobiol; 2021 Jan; 41(1):79-90. PubMed ID: 32236901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma.
    Chen J; Zhang J; Hong L; Zhou Y
    Cancer Biomark; 2019; 24(3):343-350. PubMed ID: 30829611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
    Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
    Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.
    Li S; Zhang W; Wu C; Gao H; Yu J; Wang X; Li B; Jun Z; Zhang W; Zhou P; Shi J; Wang L; Gao Y; Li S; Tao B
    FEBS J; 2018 Jun; 285(12):2278-2291. PubMed ID: 29676849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
    Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
    BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
    Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
    J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
    Ni H; Ji D; Huang Z; Li J
    Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
    Feng X; Li T; Liu Z; Shi Y; Peng Y
    Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
    Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways.
    Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G
    Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines.
    Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F
    J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.